Subscribe To
Gopro, inc. (gpro) ceo nicholas woodman on q4 2021 results - earnings call transcript
GoPro, Inc. (GPRO) CEO Nicholas Woodman on Q4 2021 Results - Earnings Call Transcript...
February 3, 2022, 9:34 pm
Gopro, inc. (gpro) ceo nicholas woodman on q4 2021 results - earnings call transcript
GoPro, Inc. (GPRO) CEO Nicholas Woodman on Q4 2021 Results - Earnings Call Transcript...
February 3, 2022, 9:34 pm
Cnx resources corporation (cnx) ceo nicholas deiuliis on q4 2021 results - earnings call transcript
CNX Resources Corporation (CNX) CEO Nicholas DeIuliis on Q4 2021 Results - Earnings Call Transcript...
January 27, 2022, 3:53 pm
Cnx resources corporation (cnx) ceo nicholas deiuliis on q4 2021 results - earnings call transcript
CNX Resources Corporation (CNX) CEO Nicholas DeIuliis on Q4 2021 Results - Earnings Call Transcript...
January 27, 2022, 3:53 pm
Cnx resources corporation (cnx) ceo nicholas deiuliis on q4 2021 results - earnings call transcript
CNX Resources Corporation (CNX) CEO Nicholas DeIuliis on Q4 2021 Results - Earnings Call Transcript...
January 27, 2022, 3:53 pm
Cleanspark establishes scholarship at gwinnett technical college as part of community commitment
CleanSpark Inc (NASDAQ:CLSK) said that it has established a scholarship at Gwinnett Technical College f...
January 27, 2022, 11:25 am
Cleanspark establishes scholarship at gwinnett technical college as part of community commitment
CleanSpark Inc (NASDAQ:CLSK) said that it has established a scholarship at Gwinnett Technical College f...
January 27, 2022, 11:25 am
Cleanspark establishes scholarship at gwinnett technical college as part of community commitment
CleanSpark Inc (NASDAQ:CLSK) said that it has established a scholarship at Gwinnett Technical College f...
January 27, 2022, 11:25 am
Scholastic corporation's (schl) ceo peter warwick on q2 2022 results - earnings call transcript
Scholastic Corporation's (SCHL) CEO Peter Warwick on Q2 2022 Results - Earnings Call Transcript...
December 16, 2021, 8:50 pm
Scholastic corporation's (schl) ceo peter warwick on q2 2022 results - earnings call transcript
Scholastic Corporation's (SCHL) CEO Peter Warwick on Q2 2022 Results - Earnings Call Transcript...
December 16, 2021, 8:50 pm
Scholastic corporation's (schl) ceo peter warwick on q2 2022 results - earnings call transcript
Scholastic Corporation's (SCHL) CEO Peter Warwick on Q2 2022 Results - Earnings Call Transcript...
December 16, 2021, 8:50 pm
Scholastic (schl) appoints mary beech as chief marketing & transformation officer
Scholastic announced today that Mary Beech has been named Schol...
November 29, 2021, 8:57 pm
Scholastic (schl) appoints mary beech as chief marketing & transformation officer
Scholastic announced today that Mary Beech has been named Schol...
November 29, 2021, 8:57 pm
Scholastic (schl) appoints mary beech as chief marketing & transformation officer
Scholastic announced today that Mary Beech has been named Schol...
November 29, 2021, 8:57 pm
Northern minerals new chair a regional and rare earths industry expert
Northern Minerals Ltd (ASX:NTU) has appointed Nicholas (Nick) Curtis AM as chairman of the Board of Di...
November 23, 2021, 8:42 pm
Northern minerals new chair a regional and rare earths industry expert
Northern Minerals Ltd (ASX:NTU) has appointed Nicholas (Nick) Curtis AM as chairman of the Board of Di...
November 23, 2021, 8:42 pm
Northern minerals new chair a regional and rare earths industry expert
Northern Minerals Ltd (ASX:NTU) has appointed Nicholas (Nick) Curtis AM as chairman of the Board of Di...
November 23, 2021, 8:42 pm
Relay therapeutics highlights interim data from bile duct cancer trial
Relay Therapeutics Inc (NASDAQ: RLAY) has announced an interim data Phase 1 trial of RLY-4008 in FGFR2-altered c...
October 8, 2021, 12:24 pm
Relay therapeutics highlights interim data from bile duct cancer trial
Relay Therapeutics Inc (NASDAQ: RLAY) has announced an interim data Phase 1 trial of RLY-4008 in FGFR2-altered c...
October 8, 2021, 12:24 pm
Relay therapeutics highlights interim data from bile duct cancer trial
Relay Therapeutics Inc (NASDAQ: RLAY) has announced an interim data Phase 1 trial of RLY-4008 in FGFR2-altered c...
October 8, 2021, 12:24 pm